(ERF) Eurofins Scientific SE - Performance 17.2% in 12m
ERF performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-13.11%
#43 in Peer-Group
Rel. Strength
67.53%
#2471 in Stock-Universe
Total Return 12m
17.24%
#47 in Peer-Group
Total Return 5y
11.19%
#36 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 28.9 |
| P/E Forward | 15.1 |
| High / Low | EUR |
|---|---|
| 52 Week High | 60.42 EUR |
| 52 Week Low | 43.24 EUR |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 93.74 |
| Buy/Sell Signal +-5 | 1.88 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ERF (17.2%) vs XBI (-7.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
10.4% | 76.6% | 81.6% | 23 | 13.8 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-6.77% | -4.62% | 149% | 12.9 | 12 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
9.62% | 0.48% | 57% | 26.8 | 13.9 | 0.97 | 0.60% | 41% |
| BIM PA Biomerieux |
2.27% | 33.8% | 9.65% | 32.6 | 25.6 | 1.54 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.43% | -8.06% | 7.86% | 42.4 | 24.4 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
13.1% | 44.8% | 4.12% | 7.86 | 6.36 | 0.81 | - | 68% |
| KMDA NASDAQ Kamada |
0.29% | 36.9% | -12% | 24.6 | 20.4 | 0.81 | 48.1% | 3.93% |
| ERF PA Eurofins Scientific SE |
8.57% | 17.2% | 11.2% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: ERF vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ERF
| Total Return (including Dividends) | ERF | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 8.57% | 7.76% | 1.11% |
| 3 Months | 21.61% | -5.31% | 5.58% |
| 12 Months | 17.24% | -7.58% | 10.51% |
| 5 Years | 11.19% | -18.55% | 109.12% |
| Trend Score (consistency of price movement) | ERF | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 90.1% | 84.2% | 69.9% |
| 3 Months | 87.3% | -2.8% | 69.3% |
| 12 Months | 26.7% | -77.8% | 43.2% |
| 5 Years | -71.6% | -53.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #99 | 0.75% | 7.38% |
| 3 Month | #38 | 28.42% | 15.18% |
| 12 Month | #48 | 26.85% | 6.09% |
| 5 Years | #37 | 36.51% | -46.83% |
FAQs
Does Eurofins Scientific SE (ERF) outperform the market?
Yes,
over the last 12 months ERF made 17.24%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.58%.
Over the last 3 months ERF made 21.61%, while XBI made -5.31%.
Performance Comparison ERF vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ERF vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.5% | 7.5% | 28.3% | 7% |
| US NASDAQ 100 | QQQ | 3.7% | 7.1% | 29.1% | 8% |
| German DAX 40 | DAX | 5.7% | 9.3% | 12% | -12% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3.8% | 9.5% | 26.5% | 6% |
| Hongkong Hang Seng | HSI | 3% | 3.5% | 9.3% | -10% |
| India NIFTY 50 | INDA | 5.2% | 9.9% | 29.4% | 19% |
| Brasil Bovespa | EWZ | 1.2% | 8.1% | 8.2% | 8% |
ERF vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3.8% | 7.1% | 25.6% | -5% |
| Consumer Discretionary | XLY | 4% | 10.4% | 38.2% | -0% |
| Consumer Staples | XLP | 3.8% | 8.8% | 26.9% | 10% |
| Energy | XLE | -2.4% | 5.7% | 24.8% | 14% |
| Financial | XLF | 5.1% | 11.1% | 25.5% | -6% |
| Health Care | XLV | 1.6% | 4.2% | 28.8% | 22% |
| Industrial | XLI | 4.5% | 8.2% | 22.8% | -1% |
| Materials | XLB | 4.2% | 7.2% | 27.6% | 18% |
| Real Estate | XLRE | 3% | 7.6% | 27.4% | 4% |
| Technology | XLK | 3.2% | 6.6% | 28% | 13% |
| Utilities | XLU | 2.1% | 8% | 20% | -4% |
| Aerospace & Defense | XAR | 4.5% | 2.8% | 11.4% | -25% |
| Biotech | XBI | 3.8% | 0.8% | 39.1% | 25% |
| Homebuilder | XHB | 5.1% | 13.6% | 43.8% | 27% |
| Retail | XRT | 7.4% | 8.7% | 36.3% | 17% |
ERF vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -8.3% | -10.1% | 18.5% | 14% |
| Natural Gas | UNG | 4.3% | 11.2% | 10.1% | 32% |
| Gold | GLD | -0.1% | 2.4% | -1.8% | -30% |
| Silver | SLV | 4.3% | -2.8% | 8.8% | -5% |
| Copper | CPER | 6% | 6.9% | 13.5% | 9% |
ERF vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 2% | 7.9% | 29.8% | 21% |
| iShares High Yield Corp. Bond | HYG | 3% | 8.1% | 24.7% | 8% |